December 05, 2024
Pfizer heads to an administrative board at the U.S. Patent and Trademark Office next week to argue Moderna should not have been issued patents covering "a basic idea" like using mRNA to fight the COVID-19 virus. Here's a spotlight on that case — plus all the other major intellectual property matters on deck in the coming week.
April 12, 2023
Swiss pharmaceutical giant Novartis AG filed a patent infringement suit Monday claiming China's Nanjing Noratech Pharmaceutical Co. is attempting to manufacture and distribute a generic version of the heart medication Entresto before Novartis' patents on the product expire.